ISPOR - Analysis Of Indication Expansions For Orphan-Designated, FDA-Approved Drugs Launched In The United States Between 2005 And 2015

Full Text

Analysis Of Indication Expansions For Orphan-Designated, FDA-Approved Drugs Launched In The United States Between 2005 And 2015

Abstract

Authors

J Li R Lai A Asabere A Bastian

Back to Volume 19, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now